XML 39 R25.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2022
Stockholders' Equity [Abstract]  
Schedule of preferred stock
   As of December 31, 2022 and 2021 
   Preferred Shares
Outstanding
   Liquidation Preference
(Per Share)
   Total Liquidation
Preference
 
Series C-3   2,000   $10.00   $20,000 
Series E   89,623   $49.20   $4,409,452 
Series G   89,999   $187.36   $16,862,213 
Total   181,622        $21,291,665 

 

Schedule of fair value of each stock option award estimated
   Shares Underlying Stock Options   Weighted-
Average
Exercise
Price
   Weighted-
Average
Remaining Contractual Term (Years)
   Aggregate Intrinsic Value 
Outstanding at December 31, 2021   3,358,131   $7.53    6.8   $337,075 
Granted   1,627,850   $3.83        $793,792 
Exercised   
-
    
-
        $
-
 
Expired/Canceled   (60,053)  $8.00        $4,968 
Forfeited   (471,559)  $7.16        $12,849 
Outstanding at December 31, 2022   4,454,369   $6.21    6.6   $1,113,050 
Vested at December 31, 2022   2,638,516   $7.26    5.0   $366,528 
Expected to vest in the future   1,815,853   $4.69    8.9   $746,522 

 

Schedule of warrant activities
   Shares Underlying Warrants   Weighted
Average
Exercise
Price
   Weighted Average Remaining Contractual Life 
Outstanding at December 31, 2021   56,455   $5.25    0.61 
Exercised   (24,500)  $5.25    
-
 
Expired   (31,955)  $5.25    
-
 
Outstanding at December 31, 2022   
-
    
-
    
-
 

 

Black-Scholes Option [Member]  
Stockholders' Equity [Abstract]  
Schedule of fair value assumptions
   Year Ended December 31, 
   2022   2021 
Risk-free interest rate   1.76% - 4.31%    0.5% - 1.26% 
Expected volatility   89.68% - 107.2%    102.93% - 107.1% 
Expected term (years)   2.75 – 5 years    1.97-5 years 
Expected dividend yield   0.0%   0.0%
Weighted-average grant date fair value of options granted during the period  $2.90   $5.56